259 related articles for article (PubMed ID: 34199622)
1. Update on PET Tracer Development for Muscarinic Acetylcholine Receptors.
Ozenil M; Aronow J; Millard M; Langer T; Wadsak W; Hacker M; Pichler V
Pharmaceuticals (Basel); 2021 Jun; 14(6):. PubMed ID: 34199622
[TBL] [Abstract][Full Text] [Related]
2. PET Imaging of Cholinergic Neurotransmission in Neurodegenerative Disorders.
Tiepolt S; Meyer PM; Patt M; Deuther-Conrad W; Hesse S; Barthel H; Sabri O
J Nucl Med; 2022 Jun; 63(Suppl 1):33S-44S. PubMed ID: 35649648
[TBL] [Abstract][Full Text] [Related]
3. In vivo visualization of central muscarinic receptors using [11C]quinuclidinyl benzilate and positron emission tomography in baboons.
Varastet M; Brouillet E; Chavoix C; Prenant C; Crouzel C; Stulzaft O; Bottlaender M; Cayla J; Mazière B; Mazière M
Eur J Pharmacol; 1992 Mar; 213(2):275-84. PubMed ID: 1521561
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Pharmacological Characterization and In Vivo Validation of LSN3172176 a Novel M1 Selective Muscarinic Receptor Agonist Tracer Molecule for Positron Emission Tomography.
Mogg AJ; Eessalu T; Johnson M; Wright R; Sanger HE; Xiao H; Crabtree MG; Smith A; Colvin EM; Schober D; Gehlert D; Jesudason C; Goldsmith PJ; Johnson MP; Felder CC; Barth VN; Broad LM
J Pharmacol Exp Ther; 2018 Jun; 365(3):602-613. PubMed ID: 29643252
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic acetylcholine receptors for psychotic disorders: bench-side to clinic.
Yohn SE; Weiden PJ; Felder CC; Stahl SM
Trends Pharmacol Sci; 2022 Dec; 43(12):1098-1112. PubMed ID: 36273943
[TBL] [Abstract][Full Text] [Related]
6. M1 muscarinic acetylcholine receptor in Alzheimer's disease.
Jiang S; Li Y; Zhang C; Zhao Y; Bu G; Xu H; Zhang YW
Neurosci Bull; 2014 Apr; 30(2):295-307. PubMed ID: 24590577
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of
Nabulsi NB; Holden D; Zheng MQ; Bois F; Lin SF; Najafzadeh S; Gao H; Ropchan J; Lara-Jaime T; Labaree D; Shirali A; Slieker L; Jesudason C; Barth V; Navarro A; Kant N; Carson RE; Huang Y
J Nucl Med; 2019 Aug; 60(8):1147-1153. PubMed ID: 30733324
[TBL] [Abstract][Full Text] [Related]
8. PET Imaging of brain muscarinic receptors with
Rowe CC; Krishnadas N; Ackermann U; Doré V; Goh RYW; Guzman R; Chong L; Bozinovski S; Mulligan R; Kanaan R; Dean B; Villemagne VL
Psychiatry Res Neuroimaging; 2021 Oct; 316():111354. PubMed ID: 34399286
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, Biological, and Computational Evaluation of Antagonistic, Chiral Hydrobenzoin Esters of Arecaidine Targeting mAChR M1.
Ozenil M; Aronow J; Piljak D; Vraka C; Holzer W; Spreitzer H; Wadsak W; Hacker M; Pichler V
Pharmaceuticals (Basel); 2020 Nov; 13(12):. PubMed ID: 33266067
[TBL] [Abstract][Full Text] [Related]
10. In vivo imaging of muscarinic cholinergic receptors in temporal lobe epilepsy with a new PET tracer: [76Br]4-bromodexetimide.
Dupont S; Semah F; Loc'h C; Strijckmans V; Baulac M; Samson Y; Mazière B
J Nucl Med; 1999 Jun; 40(6):935-41. PubMed ID: 10452308
[TBL] [Abstract][Full Text] [Related]
11. Muscarinic acetylcholine receptor (mAChR) inhibitor from snake venom: interaction with subtypes of human mAChR.
Miyoshi S; Tu AT
Arch Biochem Biophys; 1999 Sep; 369(1):114-8. PubMed ID: 10462446
[TBL] [Abstract][Full Text] [Related]
12. Muscarinic receptor subtypes differentially control synaptic input and excitability of cerebellum-projecting medial vestibular nucleus neurons.
Zhu Y; Chen SR; Pan HL
J Neurochem; 2016 Apr; 137(2):226-39. PubMed ID: 26823384
[TBL] [Abstract][Full Text] [Related]
13. Preparation of a First
Zlatopolskiy BD; Neumaier F; Rüngeler T; Drewes B; Kolks N; Neumaier B
Molecules; 2020 Jun; 25(12):. PubMed ID: 32585815
[TBL] [Abstract][Full Text] [Related]
14. Identification of putative muscarinic acetylcholine receptor genes in Bactrocera dorsalis and functional analysis of Bdor-mAChR-B.
Li JF; Zhang XY; Bai X; Su HA; Liu YL; Lu YY; Qi YX
Insect Biochem Mol Biol; 2021 Dec; 139():103657. PubMed ID: 34582990
[TBL] [Abstract][Full Text] [Related]
15. Endocannabinoids Mediate Muscarinic Acetylcholine Receptor-Dependent Long-Term Depression in the Adult Medial Prefrontal Cortex.
Martin HG; Bernabeu A; Lassalle O; Bouille C; Beurrier C; Pelissier-Alicot AL; Manzoni OJ
Front Cell Neurosci; 2015; 9():457. PubMed ID: 26648844
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic receptor subtype distribution in the central nervous system and relevance to aging and Alzheimer's disease.
Lebois EP; Thorn C; Edgerton JR; Popiolek M; Xi S
Neuropharmacology; 2018 Jul; 136(Pt C):362-373. PubMed ID: 29138080
[TBL] [Abstract][Full Text] [Related]
17. Tonic inhibition of brown adipose tissue sympathetic nerve activity via muscarinic acetylcholine receptors in the rostral raphe pallidus.
Conceição EPS; Madden CJ; Morrison SF
J Physiol; 2017 Dec; 595(24):7495-7508. PubMed ID: 29023733
[TBL] [Abstract][Full Text] [Related]
18. Targeting Muscarinic Acetylcholine Receptors for the Treatment of Psychiatric and Neurological Disorders.
Moran SP; Maksymetz J; Conn PJ
Trends Pharmacol Sci; 2019 Dec; 40(12):1006-1020. PubMed ID: 31711626
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological and molecular characterization of the A-type muscarinic acetylcholine receptor from Anopheles gambiae.
Pilon A; Goven D; Raymond V
Insect Mol Biol; 2022 Aug; 31(4):497-507. PubMed ID: 35357052
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic acetylcholine receptors in the hippocampus, neocortex and amygdala: a review of immunocytochemical localization in relation to learning and memory.
van der Zee EA; Luiten PG
Prog Neurobiol; 1999 Aug; 58(5):409-71. PubMed ID: 10380240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
